Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Sonelokimab for Hidradenitis Suppurativa
Recruiting1 awardPhase 3
South Jordan, Utah
This trial will test a new drug called sonelokimab to see if it is effective and safe for treating adults with moderate to severe hidradenitis suppurativa. Participants will be randomly
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service